María Dolores
Lozano Escario
Consultora Médica
Centro de Investigación Biomédica en Red de Cáncer
Madrid, EspañaPublications en collaboration avec des chercheurs de Centro de Investigación Biomédica en Red de Cáncer (19)
2024
-
Immunotherapy and lung cytopathology: Overview and possibilities
Cytopathology, Vol. 35, Núm. 2, pp. 213-217
-
Lung Cancer Screening in People With COPD: The Pamplona-IELCAP Experience
Archivos de Bronconeumologia, Vol. 60, Núm. 2, pp. 95-100
-
Spatially resolved tissue imaging to analyze the tumor immune microenvironment: beyond cell-type densities
Journal for immunotherapy of cancer, Vol. 12, Núm. 5
-
Tracking dynamic evolution of low- and intermediate-risk differentiated thyroid cancer: Identification of individuals at risk of recurrence
Clinical Endocrinology, Vol. 101, Núm. 3, pp. 286-294
2023
-
Molecular/biomarker testing in lung cytology: A practical approach
Diagnostic Cytopathology, Vol. 51, Núm. 1, pp. 59-67
-
Weakly supervised deep learning to predict recurrence in low-grade endometrial cancer from multiplexed immunofluorescence images
npj Digital Medicine, Vol. 6, Núm. 1
2022
-
Neutrophil Extracellular Traps, Local IL-8 Expression, and Cytotoxic T-Lymphocyte Response in the Lungs of Patients With Fatal COVID-19
Chest, Vol. 162, Núm. 5, pp. 1006-1016
2021
-
A model based on the quantification of complement C4c, CYFRA 21-1 and CRP exhibits high specificity for the early diagnosis of lung cancer
Translational Research, Vol. 233, pp. 77-91
-
Heterogenous presence of neutrophil extracellular traps in human solid tumours is partially dependent on IL-8
Journal of Pathology, Vol. 255, Núm. 2, pp. 190-201
-
Molecular biomarkers in early stage lung cancer
Translational Lung Cancer Research, Vol. 10, Núm. 2, pp. 1165-1185
-
Multiplex RNA-based detection of clinically relevant MET alterations in advanced non-small cell lung cancer
Molecular Oncology, Vol. 15, Núm. 2, pp. 350-363
-
Surgical Outcomes in a Lung Cancer-Screening Program Using Low Dose Computed Tomography
Archivos de Bronconeumologia, Vol. 57, Núm. 2, pp. 101-106
-
Utilisation of cytological samples for multiplex immunofluorescence assay
Cytopathology, Vol. 32, Núm. 5, pp. 611-616
2020
-
Diverse immune environments in human lung tuberculosis granulomas assessed by quantitative multiplexed immunofluorescence
Modern Pathology, Vol. 33, Núm. 12, pp. 2507-2519
2019
-
Expression analysis and significance of PD-1, LAG-3, and TIM-3 in human non-small cell lung cancer using spatially resolved and multiparametric single-cell analysis
Clinical Cancer Research, Vol. 25, Núm. 15, pp. 4663-4673
-
Identification of mutations associated with acquired resistance to sunitinib in renal cell cancer
International Journal of Cancer, Vol. 145, Núm. 7, pp. 1991-2001
-
Programmed death–ligand 1 expression on direct Pap-stained cytology smears from non–small cell lung cancer: Comparison with cell blocks and surgical resection specimens
Cancer Cytopathology, Vol. 127, Núm. 7, pp. 470-480
2018
-
A novel protein-based prognostic signature improves risk stratification to guide clinical management in early-stage lung adenocarcinoma patients
Journal of Pathology, Vol. 245, Núm. 4, pp. 421-432
-
Epigenetic prediction of response to anti-PD-1 treatment in non-small-cell lung cancer: a multicentre, retrospective analysis
The Lancet Respiratory Medicine, Vol. 6, Núm. 10, pp. 771-781